In het kader van het Passende Zorg Verbetertraject Osteoporose is het evaluatierapport gepubliceerd. ✨ We zijn trots dat Panaxea, in samenwerking met Amsterdam UMC, heeft mogen bijdragen aan dit onderzoek. 🔎 Het evaluatierapport toont mooie ontwikkelingen, zoals de herziening van de multidisciplinaire richtlijn, de oprichting van fractuurpreventiepoliklinieken in ziekenhuizen, en verbeterde scholing, patiënten informatie en keuzehulpen. Ook werden goede voorbeelden in kaart gebracht, waaronder samenwerkingsverbanden tussen de eerste en tweede lijn die streven naar betere therapietrouw en preventie. Toch blijven er uitdagingen bestaan: het aantal uitgevoerde DXA-scans, essentieel voor de opsporing van osteoporose, blijft laag. Ook blijft samenwerking tussen eerste en tweede lijn vaak een uitdaging vanwege niet-aansluitende richtlijnen, onvoldoende afspraken en een gebrek aan structurele financiering. 💡 Langdurige samenwerking is een belangrijke voorwaarde voor het realiseren van Passende Zorg. Dit vereist duidelijke afspraken, structurele financiering en afstemming tussen partijen. Alleen zo kunnen we zorg duurzaam verbeteren. Regionale initiatieven laten zien wat mogelijk is; nu is het tijd om van elkaar te leren en goede voorbeelden op te schalen naar landelijke impact. 🔗 Bekijk het rapport via https://lnkd.in/eK5iTqJg Iris Groeneveld, Zorginstituut Nederland, Petra Elders, Bert Vrijhoef, PhD, Ysanne de Graaf, Anam Ahmed, PhD
PANAXEA
Onderzoeksdiensten
’s-Hertogenbosch, North Brabant 676 volgers
Adding Evidence to Health Care Innovation.
Over ons
Panaxea supports informed decision making about healthcare innovation to improve health outcomes. In doing so, we add evidence to healthcare innovation by applying (early) health technology assessment, health services and policy research, and implementation science. We translate evidence into understandable, meaningful and actionable recommendations. We work together with our clients in defining the objectives and scope of work as well as the timelines and deliverables. In collecting and analyzing data we work systematically and objectively and follow international standards for research. We communicate with our clients from start to finish. We offer services to our clients for them to act upon the insights obtained. Our clients include health and life science innovators and investors, hospitals, health technology companies, governmental bodies, public and private payers, pharmaceutical companies, think tanks, and universities. Most of our clients are based in Europe, North America, and/or South-East Asia. Our team consists of experienced researchers and research consultants who understand the challenges of closing the innovation gap in healthcare. Our team is very experienced in translating findings from research to support decision making for better health outcomes.
- Website
-
http://www.panaxea.eu
Externe link voor PANAXEA
- Branche
- Onderzoeksdiensten
- Bedrijfsgrootte
- 2-10 medewerkers
- Hoofdkantoor
- ’s-Hertogenbosch, North Brabant
- Type
- Particuliere onderneming
- Opgericht
- 2010
- Specialismen
- Health Economics, Health Technology Assessment, Outcomes Research, Strategic Advice, Consulting, Medical Devices, Diagnostics, Market Access, Health Services Research, Health Policy Research, Mixed Methods Research, Survey research, Focus group interviews, Realist evaluation, Healthcare, Innovation, Scientific publications, Workshops, Nursing research, Care coordination, Integrated care, Person centred healthcare, Smart hospital en Non communicable diseases
Locaties
-
Primair
Pettelaarpark 84
’s-Hertogenbosch, North Brabant 5216 PP, NL
Medewerkers van PANAXEA
Updates
-
PANAXEA heeft dit gerepost
#EHTEL_Symposium participants are looking at the building blocks of a learning #healthsystem: the importance of human and data connections along the #digitalhealth value chain, how new processes are integrated and new knowldge generated. Thank you: ⭐ Janette Hughes for showing how to shift the focus from #treatement to #prevention through the #digitalsolutions developed by the Digital Health & Care Innovation Centre Scotland ⭐Bert Vrijhoef, PhD for highlighting the levels and inplementation strategies of value-based #healthcare transformation, as experienced by PANAXEA and Laurel - Actionable policies for integrated long-term care ⭐ Juan Carlos Contel for explaining how health and social care services work together in Catalonia, through the integration of Snomed CT in TIC Salut Social Foundation 's work. ⭐ Rachelle Kaye for moderating the session. Session supporter: Laurel - Actionable policies for integrated long-term care
-
This week AIDPATH’s (AI powered, Decentralized Production for Advanced Therapies in the Hospital) consortium meeting was held in person in Aachen. The AIDPATH platform has been moved to its final destination at Wurzburg and is now being installed and tested. Also, the 12-month extension of the project has been approved by the EU (Horizon 2020). The extension allows us to test the platform and further optimize the project. Exiting times ahead for the consortium! In this project, we are involved in the economic evaluation, business model development and a study regarding trust and acceptance of AI. For more information regarding the latter, please take a look at: https://lnkd.in/dQRgpxaa We will share publications regarding the other two WPs in due future! Fraunhofer-Gesellschaft, Forth, IRIS Technology, Red Alert Labs, Sartorius CellGenix GmbH, Hitachi Chemical, AGLARIS CELL SL, Universitätsklinikum Würzburg, ORTEC, Fundació Clínic per a la Recerca Biomèdica, HUN-REN SZTAKI (Institute for Computer Science and Control), UCL, PANAXEA
-
PANAXEA heeft dit gerepost
#ISPOREurope 2024 has started and PANAXEA is present! After a promising start I am looking forward to the presentations, discussions and acquaintances the comimg days. Interested to learn how Panaxea could add evidence to your healthcare innovation? Feel free to send me a message and lets grab a coffee together. One of Panaxea's work, the results of a cost-effectiveness analysis of cell-based therapies for the treatment of osteoarthritis, will be presented during the fifth poster tour on Wednesday morning at poster board 1079. I hope to meet you there. #healtheconomics #HEOR #HTA #Panaxea #InnovateInformImprove #posterpresentation #healthcareinnovationresearch
-
PANAXEA heeft dit gerepost
Interested to add evidence to your healthcare innovation? Have a chat with our colleague Iris Boot during ISPOR Europe conference. During poster session 5, she will present the findings of a cost-effectiveness analysis of cell-based therapies for the treatment of people with osteoarthritis. Make sure to meet us in Barcelona on Wednesday November 20 from 9.00 until 11.30, poster session 5. Of course we will also be available on other days during the conference to discuss how we can help you in adding evidence to your healthcare innovation. If that doesn’t work for you, please contact us via: [email protected] ISPOR—The Professional Society for Health Economics and Outcomes Research AutoCRAT #ISPOREurope2024 #healthresearch #InnovateInformImprove #healtheconomics #HEOR #HTA #Panaxea #posterpresentation #osteoarthritis #cellbasedtherapies #healthcareinnovationresearch
-
Interested to add evidence to your healthcare innovation? Have a chat with our colleague Iris Boot during ISPOR Europe conference. During poster session 5, she will present the findings of a cost-effectiveness analysis of cell-based therapies for the treatment of people with osteoarthritis. Make sure to meet us in Barcelona on Wednesday November 20 from 9.00 until 11.30, poster session 5. Of course we will also be available on other days during the conference to discuss how we can help you in adding evidence to your healthcare innovation. If that doesn’t work for you, please contact us via: [email protected] ISPOR—The Professional Society for Health Economics and Outcomes Research AutoCRAT #ISPOREurope2024 #healthresearch #InnovateInformImprove #healtheconomics #HEOR #HTA #Panaxea #posterpresentation #osteoarthritis #cellbasedtherapies #healthcareinnovationresearch
-
PANAXEA heeft dit gerepost
🚚 Finally all packed up and off we go: after a little more than 3.5 years, the "Automated AI-driven CAR-T Manufacturing Platform" is now making its way to Würzburg. In the last few years, the scientists at the Fraunhofer-Institut für Produktionstechnologie IPT, in collaboration with the AIDPATH consortium partners, have created the platform design, assembled the required devices, built the platform, connected the devices and tested the platform extensively. The centrepiece of AIDPATH is leaving the laboratories in Aachen to be tested at its final location at the Universitätsklinikum Würzburg. This farewell also means a big step towards the goal of AIDPATH! Partners: Aglaris Ltd Group Sartorius CellGenix GmbH IRIS Technology Solutions Fraunhofer IZI Foundation for Research and Technology - Hellas (FORTH) ORTEC PANAXEA Fundació Clínic per a la Recerca Biomèdica Red Alert Labs UCL BioSci Consulting #CART
-
PANAXEA heeft dit gerepost
⌛ The time has come: one of the most important steps in the AIDPATH project is just around the corner. After intensive work in recent years, the move of the AIDPATH platform to its final destination at the Universitätsklinikum Würzburg is being prepared. The packing is in full swing. 📦 The project partners at the Fraunhofer-Institut für Produktionstechnologie IPT have prepared the first part of the system, the liquid handling unit, for transport. It's ready to go! Aglaris Ltd Group Sartorius CellGenix GmbH IRIS Technology Solutions Fraunhofer IZI Foundation for Research and Technology - Hellas (FORTH) ORTEC PANAXEA Fundació Clínic per a la Recerca Biomèdica Red Alert Labs UCL BioSci Consulting